Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) EBT Margin (QoQ) (2020 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10,723.00
Mar 31, 2026 -14,725.00
Dec 31, 2025 -3,579.00
Sep 30, 2025 -7,128.00
Jun 30, 2025 8,104.00
Mar 31, 2025 2,830.00
Dec 31, 2024 -18,223.00
Sep 30, 2024 32,230.00
Jun 30, 2024 5,111.00
Mar 31, 2024 -35,000.00
Dec 31, 2023 45,931.00
Sep 30, 2023 -33,145.00
Jun 30, 2023 3,885.00
Mar 31, 2023 -6,276.00
Dec 31, 2022 81,818.00
Sep 30, 2022 -54,559.00
Jun 30, 2022 -11,172.00
Mar 31, 2022 72,931.00
Dec 31, 2021 -94,909.00
Sep 30, 2021 -641.00